The FDA has approved the topical phosphodiesterase 4 (PDE4) inhibitor difamilast (Adquey) as a new option for mild/moderate ...

LAS VEGAS -- Implementing a substance use screening program for pregnant patients admitted for delivery was associated with a ...

Faster longitudinal tau accumulation occurred in women across multiple brain regions. Elevated p-tau217 predicted more rapid ...

BridgeBio Pharma's infigratinib, an investigational drug that addresses the underlying cause of achondroplasia, significantly improved annualized height velocity in children with open growth plates ...

From expanding care delivery options to eliminating red tape and investing in mental health, experts shared ways lawmakers can keep physicians from leaving practice during a Senate hearing this week. ...

Solriamfetol (Sunosi), a selective dopamine and norepinephrine reuptake inhibitor, improved sleepiness compared with placebo ...

Every day, we seem to be inundated with more and more innovations and new technologies, whizbang cool devices, software, and blood tests. It's getting easier and easier to test and detect more and ...

In " Beyond Diagnosis: Breast Cancer," Cleveland Clinic oncologist Tiffany Onger, MD, and host John Mangels continue their ...

Three drugs that inhibit the immunoglobulin G (IgG) neonatal fragment crystallizable receptor (FcRn) were approved to treat ...

As I type this, I am fighting back my own tears. Our reality is heartbreaking. But my tears are also filled with something else: frustration. Frustration that once again, medicine and science seem to ...

Rheumatoid arthritis (RA) patients face increased risk for interstitial lung disease (ILD) that is worsened further by the ...